Montisera Strengthens Executive Management Team by Appointing New CEO
(Montisera, Raisio; June 22, 2016, 10:11 ) – Montisera Ltd, a Finnish development company focused on developing and commercialising bioactive compounds, have announced today that it has strengthened its Executive Management Team with the appointment of PhD, eMBA Mira Povelainen as its new CEO.
Dr. Povelainen joins Montisera from Raisio Group, where she has worked as Head of Research and Development and Quality Assurance supporting Raisio’s Brands division. Dr. Povelainen has PhD in Biotechnology and has 17 years’ experience of industrial R&D and informatics with background of Danisco (DuPont) in addition to Raisio. “When I first heard about Montisera and its business model, I was immediately interested and inspired. In my previous positions I have seen that to enable the full potential of bioeconomy there is a clear need for agile development companies like Montisera. These can operate between the traditional industry sectors, like food, forests and pharma industries.”
Dr. Povelainen will start in her position in August and will be responsible for overseeing Montisera´s strategy in developing and commercialising bioactive compounds with health benefits for food and pharma sectors. Heikki Vuorikoski, founder, board member and current CEO of Montisera will continue in Montisera as Business Development Director.
“We are delighted to welcome Dr. Povelainen to our passioned Executive Management Team. Her appointment comes at an exciting time for Montisera as we are heading into clinical activities, and have just announced major news about acquiring IPR’s and patents from UPM within the field of biomass extraction for the purpose of human health and well-being.”, says Vuorikoski. “Dr. Povelainen’s experience in international plant-based nutrition and R&D will provide an invaluable insight into the needs of both strategy and agri-food sector.”, Kalle Reponen, Chairman of the Board of Montisera says.
For further information please contact:
Heikki Vuorikoski, CEO, Montisera Ltd. tel. +358 40 756 2427
Founded in 2012, Montisera is a privately-owned Finnish development company focused on discovering, developing and commercialising bioactive compounds from its development platform to be used in novel products in the pharmaceutical and food industries. Montisera’s focus is on the management of its global partner network of universities, science companies, laboratories, contract research organisations (CROs) etc. Montisera currently has three bioactive compounds in its development platform in different stages of the development pipeline, ranging from Parkinson’s disease to alcoholism and lower urinary tract diseases.